• Join
  • Login
  • Contact

Search abstracts

The evaluation of efficacy and safety of new Iranian filgrastim brand drug (PDgrastim*) in treatment of leukemic patients neutropenia

  • At: Basel (Switzerland) (2008)
  • Type: Poster
  • By: SOHREVARDI, Seyed mojtaba (Faculty of pharmacy, Kerman, Iran)
  • Co-author(s): Kalantari, Behjat (Faculty of medicine, Kerman, Iran)
    Jalali, Seyed pouyan (Faculty of medicine, Kerman, Iran)
  • Abstract:

    The acute leukemias are clonal hematopoietic malignant disease that arise from the malignant transformation of an early hematopoietic stem cell, leukemia occurs in 8 to 10 in 100,000 people. these patients usually suffer than several weeks of neutropenia due to chemotherapy. We decided to evaluate the efficacy and safety of PDgrastim* (The new


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses